Samuel Copeland is a Respiratory physician. OpenAlex indexes 17 publications with 203 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2705 Hospital Dr Ste 402
Victoria, TX 779015777
Telephone
361-574-1780Registry record last updated 11 Jul 2019.
Industry payments
17 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year202511 payments
- GlaxoSmithKline, LLC.Program year202519 payments
- Baxter HealthcareProgram year20257 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
86.8%Corticosteroid52.6%Trelegy Ellipta51%Breo Ellipta18%Symbicort11%Breztri Aerosphere9%Budesonide-Formoterol Fumarate6%Breyna3%Fluticasone Propionate2%Part D<11 patientsbeta2-Adrenergic Agonist21.9%Albuterol Sulfate Hfa93%Ventolin Hfa7%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
5.2%Corticosteroid3.8%Prednisone100%Part D≥29 patientsProton pump inhibitor1.4%Pantoprazole Sodium100%Part D<11 patientsCancer & immunology
4.5%Kinase inhibitor3.7%Ofev100%Part D<11 patientsFolate Analog Metabolic Inhibitor0.8%Methotrexate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Tim Driscoll
The University of Sydney
Francesco Saverio Violante
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola
Mark A. Rubin
University of Bern
Marc Humbert
Inserm
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”